TRACY BEASLEY: Open Payments
NPI 1316392384 · PHILADELPHIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 47 payments from 16 companies in 2025. Trend: 2023 $510 · 2024 $272 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $185 |
| ABBVIE INC. | 11 | $140 |
| Novo Nordisk Inc | 5 | $93 |
| Exact Sciences Corporation | 4 | $75 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Dexcom, Inc. | 2 | $48 |
| Lilly USA, LLC | 3 | $44 |
| Astellas Pharma US Inc | 2 | $34 |
| SI-BONE, INC. | 1 | $26 |
| Corcept Therapeutics | 1 | $25 |
Products named: JARDIANCE, VRAYLAR, Cologuard Collection Kit, OFEV, Dexcom G6 Transmitter, MOUNJARO, AREXVY, Veozah.
Industry payments across MS — which companies pay providers there.
